Sperax USD vs USDS

USDS (USDS) is 18619.7× the size of Sperax USD (USDS) by market capitalisation. Over the past 90 days, USDS is ahead by 0.1 percentage points (USDS -0.1% against USDS +0.0%). Their daily returns move barely together (correlation 0.01 across 183 shared trading days). Both have run at a similar volatility, around 1% annualised.

Correlation: 0.01
Size ratio: 1 : 18619.7
Ahead over 90 days: USDS

Sperax USDUSDS

$0.998856

24h: +0.22%
Market cap: $514,256
Volume 24h: $62,081
Volatility (ann.): 1%

USDSUSDS

$0.999986

24h: +0.01%
Market cap: $9.58B
Volume 24h: $202.40M
Volatility (ann.): 1%

USDS 0.0%Share of the two combined market caps100.0% USDS

Performance

USDSUSDS

7 days-0.16%-0.02%USDS
30 days-0.02%+0.09%USDS
90 days-0.07%+0.01%USDS

Correlation

0.01over 183 shared trading days

−1 opposite0 unrelated+1 in step

7d: insufficient data30d: -0.1390d: -0.051y: insufficient data

Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.

Risk & extremes

Metric	USDS	USDS
Max drawdown (400d)	-0.2%	-0.4%
Risk-adjusted return (90d)	-0.09	0.01

Relative strength over 90 days: USDS outperformed USDS by 0.1% — measured on the USDS/USDS ratio, so it holds regardless of market direction.

Sperax USD →USDS →